Albendazole

Active ingredient description

Αlbendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Albendazole
P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Medicines

Albendazole is the active ingredient of these drugs:

Drug
Countries

Brazil

Singapore

Brazil

United States

Singapore

Lithuania

Australia Austria France Lithuania Netherlands

Lithuania

Brazil

Brazil

Tunisia

Brazil

Tunisia

Tunisia

Australia France Singapore

Cyprus

Brazil

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

F4216019LN - ALBENDAZOLE

CAS registry number

54965-21-8 - albendazole

SNOMED-CT

387558006 - Albendazole (substance)